What it's for (Indications)
- Ramipril + hydrochlorothiazide is a fixed-dose combination medication primarily indicated for the treatment of essential hypertension.
- This therapy is specifically prescribed for adult patients whose blood pressure is not adequately controlled by monotherapy with ramipril or hydrochlorothiazide alone.
- It is also suitable for patients who have demonstrated stable blood pressure control while taking the individual components at the same dosages as present in the combination product.
- The synergistic action of an angiotensin-converting enzyme (ACE) inhibitor (ramipril) and a thiazide diuretic (hydrochlorothiazide) provides a comprehensive approach to blood pressure reduction, particularly beneficial in cases where fluid retention or inadequate response to single-agent therapy is a concern.
- The combination aims to achieve optimal blood pressure targets, thereby reducing the risk of cardiovascular morbidity and mortality associated with uncontrolled hypertension.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Specific dosage guidelines are not provided in the source data. Dosage should be individualized based on patient response and tolerability, typically initiating with the lowest effective dose. |
Safety & Warnings
Common Side Effects
- The combination of ramipril and hydrochlorothiazide can lead to a range of side effects, which are generally a summation of the adverse effects associated with each component.
- Common side effects often include dizziness, fatigue, headache, and a dry, persistent cough (a characteristic adverse effect of ACE inhibitors).
- Orthostatic hypotension, characterized by a sudden drop in blood pressure upon standing, is also frequently reported due to the combined antihypertensive effects.
- Electrolyte imbalances are a significant concern, with hydrochlorothiazide predisposing patients to hypokalemia, hyponatremia, and hypomagnesemia, while ramipril can cause hyperkalemia; therefore, careful monitoring of serum electrolytes is crucial.
- Other potential side effects may include gastrointestinal disturbances like nausea, vomiting, or diarrhea.
- More serious, though less common, adverse reactions include angioedema (swelling of the face, lips, tongue, glottis, and larynx, which can be life-threatening), significant renal dysfunction (especially in patients with pre-existing kidney disease or bilateral renal artery stenosis), severe hypotension, pancreatitis, and blood dyscrasias.
- Photosensitivity reactions have also been reported with hydrochlorothiazide.
- Patients should be advised to report any unusual or severe symptoms to their healthcare provider promptly.
Serious Warnings
- Black Box Warning: WARNING: FETAL TOXICITY. Ramipril, a key component of this combination product, can cause severe injury and even death to the developing fetus when administered to pregnant women. This risk is particularly significant during the second and third trimesters of pregnancy. If pregnancy is detected, ramipril/hydrochlorothiazide should be discontinued as soon as possible. Drugs that act directly on the renin-angiotensin system (RAS), including angiotensin-converting enzyme (ACE) inhibitors, have been consistently associated with fetal and neonatal morbidity and mortality. Observed adverse effects in humans include oligohydramnios, which can lead to fetal lung hypoplasia, skeletal deformations, premature birth, and intrauterine growth restriction. Additionally, patent ductus arteriosus has been reported. In neonates exposed in utero, potential adverse effects include renal failure, hypotension, hyperkalemia, and anuria, necessitating aggressive medical management. For these critical reasons, this medication is strictly contraindicated in pregnant women, and patients of childbearing potential should be counselled on the risks and the importance of effective contraception during treatment.
- Patients should avoid driving or operating heavy machinery due to potential impairment.
- Alcohol consumption should be avoided.
- Use with extreme caution, or is not suggested, in patients undergoing hemodialysis and those with liver impairments.
How it Works (Mechanism of Action)
The mechanism of action is not explicitly provided in the source data for this combination. Ramipril is an ACE inhibitor and hydrochlorothiazide is a thiazide diuretic.
Commercial Brands (Alternatives)
No other brands found for this formula.